New! Sign up for our free email newsletter.
Science News
from research organizations

Adiponectin shows potential in blocking obesity-related carcinogenesis

Date:
October 24, 2010
Source:
Wiley - Blackwell
Summary:
Researchers investigated the role between adiponectin and leptin in obesity-related carcinogenesis. Their findings suggest that the protein hormone adiponectin has potential for inhibiting the oncogenic actions of leptin, namely in hepatocellular carcinoma (HCC), and could offer a promising therapy for the disease.
Share:
FULL STORY

A research team from Emory University School of Medicine investigated the role between adiponectin and leptin in obesity-related carcinogenesis. Their findings, published in the November issue of Hepatology, suggest that the protein hormone adiponectin has potential for inhibiting the oncogenic actions of leptin, namely in hepatocellular carcinoma (HCC), and could offer a promising therapy for the disease.

Obesity is on the rise and is associated with increased risk and progression of a number of cancers including colon, prostate, breast, and liver cancers. The World Health Organization declared obesity one of the greatest public health challenges of the 21st century and projects that by 2015, more than 700 million adults will be obese. In the U.S., the Centers for Disease Control and Prevention (CDC) estimates roughly 72.5 million adults are considered obese -- having a body mass index (BMI) greater than 30.

Obese populations have higher circulating levels of leptin, the protein hormone that controls appetite, but lower concentrations of adiponectin which regulates glucose levels and the breakdown of fatty acids. Understanding the these hormones play a role in obesity-related cancers and the vast number of individuals who are at risk, Neeraj K. Saxena, Ph.D. and colleagues investigated the protective effect of adiponectin and its impact on leptin in HCC.

"Our study presents important clinical implications since HCC has the highest increased risk associated with obesity compared to other cancers such as prostate, kidney, colon, and stomach," commented Dr. Saxena. Using human cell-lines, mice models of HCC, and tissue microarray researchers determined the antagonistic role of adiponectin on the cancer-causing actions of leptin.

The authors found that adiponectin treatment inhibited leptin-induced proliferation, invasion, and migration of HCC cells. Treatment with adiponectin also slowed leptin-induced HCC tumor growth in vivo. Further analysis showed that leptin expression correlated positively with HCC proliferation and nonalcoholic steatohepatitis (NASH). Adiponectin expression had an inverse correlation with tumor size, and a direct correlation to disease-free survival in human HCC tumor samples.

"Taken together our results suggest an attractive molecular strategy employing adiponectin analogues for potential therapy of metastatic HCC," concluded Dr. Saxena. "With the prevalence of obesity in the U.S., our study could significantly improve overall survival for a vast number of obese liver cancer patients by using adiponectin to inhibit growth, invasion, and migration of HCC cells."


Story Source:

Materials provided by Wiley - Blackwell. Note: Content may be edited for style and length.


Journal Reference:

  1. Dipali Sharma, Jason Wang, Ping P. Fu, Shvetank Sharma, Arumugam Nagalingam, Jamie Mells, Jeffrey Handy, Andrew J. Page, Cynthia Cohen, Frank A. Anania, Neeraj K. Saxena. Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis. Hepatology, 2010; DOI: 10.1002/hep.23892

Cite This Page:

Wiley - Blackwell. "Adiponectin shows potential in blocking obesity-related carcinogenesis." ScienceDaily. ScienceDaily, 24 October 2010. <www.sciencedaily.com/releases/2010/10/101019090907.htm>.
Wiley - Blackwell. (2010, October 24). Adiponectin shows potential in blocking obesity-related carcinogenesis. ScienceDaily. Retrieved March 28, 2024 from www.sciencedaily.com/releases/2010/10/101019090907.htm
Wiley - Blackwell. "Adiponectin shows potential in blocking obesity-related carcinogenesis." ScienceDaily. www.sciencedaily.com/releases/2010/10/101019090907.htm (accessed March 28, 2024).

Explore More

from ScienceDaily

RELATED STORIES